{"nctId":"NCT01625897","briefTitle":"A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia","startDateStruct":{"date":"2012-05"},"conditions":["Schizophrenia"],"count":125,"armGroups":[{"label":"MP-214 1.5-9mg","type":"EXPERIMENTAL","interventionNames":["Drug: MP-214"]},{"label":"Risperidone 2-12mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Risperidone"]}],"interventions":[{"name":"MP-214","otherNames":[]},{"name":"Risperidone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Written informed consent obtained from the patient before the initiation of any study-specific procedures\n* Patients diagnosed with schizophrenia according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for schizophrenia\n* Patients who meet at least one of the following:\n\n  * current diagnosis of schizophrenia of chronic phase\n  * between 65 and 74 years of age\n* Patients with normal physical examination, laboratory, vital signs, and/or electrocardiogram (ECG)\n\nExclusion Criteria:\n\n* Patients with a DSM-IV-TR diagnosis of schizoaffective disorder, schizophreniform disorder, other psychotic disorders other than schizophrenia, or bipolar I or II disorder\n\nThe information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"74 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events as a Measure of Safety and Tolerability","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":13,"n":83},"commonTop":["Nasopharyngitis","Schizophrenia","Insomnia","Hyperprolactinaemia","Blood prolactin increased"]}}}